The concept of preventable mortality as a basis for developing mortality reduction measures: an example of cardiovascular disease

This article demonstrates how the concept of preventable mortality can be used to develop mortality reduction measures using cardiovascular disease (CVD) as an example. The measures are structured according to Donabedian model. A Russian methodology for determining preventable mortality, based on international approaches and adapted to Russian healthcare system, was used. In collaboration with federal experts, a list of measures to reduce preventable cardiovascular mortality was developed. To systematize these measures, Donabedian’s triad was used, identifying resources, processes, and performance indicators for each measure. Following activity examples are presented: "health schools" using telemedicine technologies, individual patient information, and stress echocardiography. Their structuring according to the Donabedian model makes it possible to identify the causes of potentially unsatisfactory results and improve their implementation. Integrating the concept of preventable mortality with the Donabedian model ensures a rational selection and evaluation of measures to reduce cardiovascular mortality, as well as the effective allocation of resources. The list of activities requires regular updating, taking into account changes in medical technologies and healthcare system capabilities.

1. Westerling R. Commentary: Evaluating avoidable mortality in developing countries — an important issue for public health. International Journal of Epidemiology. 2001;30:973-5. doi:10.1093/ije/30.5.973.

2. Rutstein DD, Berenberg W, Chalmers TC, et al. Measuring the Quality of Medical Care: A Clinical Method. New England Journal of Medicine. 1976;294:582-8. doi:10.1056/NEJM197603112941104.

3. Simonato L, Ballard T, Bellini P, et al. Avoidable mortality in Europe 1955-1994: a plea for prevention. Journal of Epidemiology & Community Health. 1998;52:624-30. doi:10.1136/jech.52.10.624.

4. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260(12):1743- 8. doi:10.1001/jama.260.12.1743.

5. Busse R, Klazinga N, Panteli D, et al., editors. Health Policy Series, No. 53. Copenhagen (Denmark): European Observatory on Health Systems and Policies. 2019. ISBN 13: 9789289051750.

6. Nikoloski Z, Shkolnikov VM, Mossialos E. Preventable mortality in the Russian Federation: a retrospective, regional level study. The Lancet Regional Health — Europe. 2023;29:100631. doi:10.1016/j.lanepe.2023.100631.

7. Ivanova AE, Semjonova VG, Sabgajda TP. Reserves for mortality reduction in Russia due to healthcare efficiency. Vestnik Rossijskoj akademii nauk. 2021;91(9):865-78. (In Russ.) doi:10.31857/S086958732109005X.

8. Andreev EM, Nolte E, Shkolnikov VM, et al. The evolving pattern of avoidable mortality in Russia. International Journal of Epidemiology. 2003;32:437-46. doi:10.1093/ije/dyg085.

9. Zubko A, Sabgaida T, Semyonova V, et al. Mortality Associated with Preventable Causes of Deaths from Cardio-Vascular Diseases in the Pre-Covid Period and During the Pandemic in Russia. Social Aspects of Population Health. 2023;(69):6-6. doi:10.21045/2071-5021-2023-69-1-6.

10. OECD (2023), Health at a Glance 2023: OECD Indicators, OECD Publishing, Paris. doi:10.1787/7a7afb35 en.

11. Grigoriev P, Meslé F, Shkolnikov VM, et al. The Recent Mortality Decline in Russia: Beginning of the Cardiovascular Revolution?. Population and Development Review. 2014;40:107-29. doi:10.1111/j.1728-4457.2014.00652.x.